-
At AbbVie, Machine Learning Aids Selection Of Clinical Trial Sites
Clinical Research News | At AbbVie, the introduction of machine learning into the site selection process for clinical studies is reaping tangible returns by increasing the number of sites meeting enrollment and startup time goals by more than 50%. The algorithm helps study teams identify the best sites for a particular trial based on a quantitative analysis of their performance in similar studies done in the past.
Feb 1, 2023
-
35+ New Products Eligible for Inaugural SCOPE Best of Show Awards
Clinical Research News | Clinical Research News and ClinEco are pleased to announce the finalists for the first SCOPE Best of Show Awards. Thirty-five new products presented at the Summit for Clinical Ops Executives in February in Orlando, Fla. have been chosen as finalists in the inagural awards program, recognizing the best new products enabling clinical trials and clincial research.
Jan 31, 2023
-
MD Anderson Launches Gamma-Delta T-Cell Therapy Study, New Multi-Year Multi-Omics Cancer Resistance Mechanisms Research, More
Clinical Research News | A major new initiative in cancer research to study the role and function of the non-coding genome and epigenome in multiple cancer types; the first one-stop-shop decentralized clinical trial platform bundled with site and trial execution services for the digital therapeutics market; a unique and unparalleled suite of early to late-phase CRO services across Europe, the US, and Asia Pacific; and more.
Jan 26, 2023
-
Follow the Money: PCORI Opens Nine Research Funding Opportunities, Novel Transcriptome-Wide Profiling Research, More
Clinical Research News | Funding for preclinical development and clinical proof-of-concept therapeutic studies, comparative clinical effectiveness research to help patients and other stakeholders make better-informed health choices, clinical decision support expansion for diagnostic and surveillance tools, and more.
Jan 24, 2023
